Received Feb 4, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
After the first shot I was okay no problems 6 weeks later I received the second shot; Muscle aches; headaches; chills; fever; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of muscle pain in a patient who received Herpes zoster (Shingrix) for prophylaxis. Concomitant products included Varicella zoster vaccine rgE (CHO) (Shingrix). The patient received the 2nd dose of Shingrix. The patient experienced muscle pain (Verbatim: Muscle aches), headache (Verbatim: headaches), chills (Verbatim: chills), fever (Verbatim: fever) and drug dose administration interval too short (Verbatim: After the first shot I was okay no problems 6 weeks later I received the second shot). The outcome of the muscle pain, headache, chills and fever were resolved (duration 3 days). It was unknown if the reporter considered the muscle pain, headache, chills and fever to be related to Shingrix. It was unknown if the company considered the muscle pain, headache, chills and fever to be related to Shingrix. Additional Information: GSK Receipt Date: 29-JAN-2026 This case was reported by a patient via interactive digital media. The batch number was not provided, and we are unable to contact the reporter.